In the complex landscape of cancer, tumors create their own microenvironment, often marked by low oxygen levels, a condition known as hypoxia.
New York gene therapy startup Neurogene eyes $200M from Neoleukin Nasdaq swap
Neoleukin Therapeutics has found its reverse merger partner about four months after putting up the for-sale sign, as the Seattle biotech gives way to a
July 19, 2023